Chemerin and adiponectin contribute reciprocally to metabolic syndrome

Sang Hui Chu, Mi Kyung Lee, Ki Yong Ahn, Jee Aee Im, Min Soo Park, Duk Chul Lee, Justin Y. Jeon, Ji Won Lee

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Obesity and metabolic syndrome (MetS) are considered chronic inflammatory states. Chemerin, a novel adipokine, may play an important role in linking MetS and inflammation. We investigated the association of chemerin with inflammatory markers and with characteristics of MetS in apparently healthy overweight and obese adults. We studied 92 adults; 59 men and 33 women whose average body mass index (BMI) was 28.15±5.08 kg/m 2. Anthropometric parameters, insulin resistance indices, lipid profiles, and inflammatory markers including high sensitivity C-reactive protein (hsCRP), pentraxin 3 (PTX3), adiponectin, and chemerin were measured. Controlling for age, gender, and BMI, serum chemerin level was positively correlated with body fat and serum triglyceride, and negatively correlated with adiponectin and high density lipoprotein cholesterol (HDL- C), and was not correlated with altered hsCRP or PTX3 levels. Among the low, moderate and high chemerin groups, high chemerin individuals are more likely to have lower HDL-C. Conversely, individuals in the low adiponectin group are more likely to have lower HDL-C and show more MetS phenotypic traits than moderate and high adiponectin subjects. To determine the relationships of chemerin and adiponectin to MetS and its components, participants were stratified into four groups based on their chemerin and adiponectin levels (high chemerin/high adiponectin, high chemerin/low adiponectin, low chemerin/high adiponectin, or low chemerin/low adiponectin). Participants who were in the high chemerin/low adiponectin group more likely to have dyslipidemia and MetS (OR: 5.79, 95% CI:1.00-33.70) compared to the other three group. Our findings suggest that chemerin and adiponectin may reciprocally participate in the development of MetS.

Original languageEnglish
Article numbere34710
JournalPloS one
Volume7
Issue number4
DOIs
Publication statusPublished - 2012 Apr 16

Fingerprint

adiponectin
Adiponectin
metabolic syndrome
C-reactive protein
C-Reactive Protein
body mass index
Body Mass Index
adipokines
Adipokines
hyperlipidemia
Dyslipidemias
Serum
high density lipoprotein cholesterol
insulin resistance
HDL Cholesterol
body fat
Insulin Resistance
Adipose Tissue
Triglycerides
obesity

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Chu, S. H., Lee, M. K., Ahn, K. Y., Im, J. A., Park, M. S., Lee, D. C., ... Lee, J. W. (2012). Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PloS one, 7(4), [e34710]. https://doi.org/10.1371/journal.pone.0034710
Chu, Sang Hui ; Lee, Mi Kyung ; Ahn, Ki Yong ; Im, Jee Aee ; Park, Min Soo ; Lee, Duk Chul ; Jeon, Justin Y. ; Lee, Ji Won. / Chemerin and adiponectin contribute reciprocally to metabolic syndrome. In: PloS one. 2012 ; Vol. 7, No. 4.
@article{b3ebe9c25dd5486aaf6b4e7fc7f1eb67,
title = "Chemerin and adiponectin contribute reciprocally to metabolic syndrome",
abstract = "Obesity and metabolic syndrome (MetS) are considered chronic inflammatory states. Chemerin, a novel adipokine, may play an important role in linking MetS and inflammation. We investigated the association of chemerin with inflammatory markers and with characteristics of MetS in apparently healthy overweight and obese adults. We studied 92 adults; 59 men and 33 women whose average body mass index (BMI) was 28.15±5.08 kg/m 2. Anthropometric parameters, insulin resistance indices, lipid profiles, and inflammatory markers including high sensitivity C-reactive protein (hsCRP), pentraxin 3 (PTX3), adiponectin, and chemerin were measured. Controlling for age, gender, and BMI, serum chemerin level was positively correlated with body fat and serum triglyceride, and negatively correlated with adiponectin and high density lipoprotein cholesterol (HDL- C), and was not correlated with altered hsCRP or PTX3 levels. Among the low, moderate and high chemerin groups, high chemerin individuals are more likely to have lower HDL-C. Conversely, individuals in the low adiponectin group are more likely to have lower HDL-C and show more MetS phenotypic traits than moderate and high adiponectin subjects. To determine the relationships of chemerin and adiponectin to MetS and its components, participants were stratified into four groups based on their chemerin and adiponectin levels (high chemerin/high adiponectin, high chemerin/low adiponectin, low chemerin/high adiponectin, or low chemerin/low adiponectin). Participants who were in the high chemerin/low adiponectin group more likely to have dyslipidemia and MetS (OR: 5.79, 95{\%} CI:1.00-33.70) compared to the other three group. Our findings suggest that chemerin and adiponectin may reciprocally participate in the development of MetS.",
author = "Chu, {Sang Hui} and Lee, {Mi Kyung} and Ahn, {Ki Yong} and Im, {Jee Aee} and Park, {Min Soo} and Lee, {Duk Chul} and Jeon, {Justin Y.} and Lee, {Ji Won}",
year = "2012",
month = "4",
day = "16",
doi = "10.1371/journal.pone.0034710",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

Chemerin and adiponectin contribute reciprocally to metabolic syndrome. / Chu, Sang Hui; Lee, Mi Kyung; Ahn, Ki Yong; Im, Jee Aee; Park, Min Soo; Lee, Duk Chul; Jeon, Justin Y.; Lee, Ji Won.

In: PloS one, Vol. 7, No. 4, e34710, 16.04.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chemerin and adiponectin contribute reciprocally to metabolic syndrome

AU - Chu, Sang Hui

AU - Lee, Mi Kyung

AU - Ahn, Ki Yong

AU - Im, Jee Aee

AU - Park, Min Soo

AU - Lee, Duk Chul

AU - Jeon, Justin Y.

AU - Lee, Ji Won

PY - 2012/4/16

Y1 - 2012/4/16

N2 - Obesity and metabolic syndrome (MetS) are considered chronic inflammatory states. Chemerin, a novel adipokine, may play an important role in linking MetS and inflammation. We investigated the association of chemerin with inflammatory markers and with characteristics of MetS in apparently healthy overweight and obese adults. We studied 92 adults; 59 men and 33 women whose average body mass index (BMI) was 28.15±5.08 kg/m 2. Anthropometric parameters, insulin resistance indices, lipid profiles, and inflammatory markers including high sensitivity C-reactive protein (hsCRP), pentraxin 3 (PTX3), adiponectin, and chemerin were measured. Controlling for age, gender, and BMI, serum chemerin level was positively correlated with body fat and serum triglyceride, and negatively correlated with adiponectin and high density lipoprotein cholesterol (HDL- C), and was not correlated with altered hsCRP or PTX3 levels. Among the low, moderate and high chemerin groups, high chemerin individuals are more likely to have lower HDL-C. Conversely, individuals in the low adiponectin group are more likely to have lower HDL-C and show more MetS phenotypic traits than moderate and high adiponectin subjects. To determine the relationships of chemerin and adiponectin to MetS and its components, participants were stratified into four groups based on their chemerin and adiponectin levels (high chemerin/high adiponectin, high chemerin/low adiponectin, low chemerin/high adiponectin, or low chemerin/low adiponectin). Participants who were in the high chemerin/low adiponectin group more likely to have dyslipidemia and MetS (OR: 5.79, 95% CI:1.00-33.70) compared to the other three group. Our findings suggest that chemerin and adiponectin may reciprocally participate in the development of MetS.

AB - Obesity and metabolic syndrome (MetS) are considered chronic inflammatory states. Chemerin, a novel adipokine, may play an important role in linking MetS and inflammation. We investigated the association of chemerin with inflammatory markers and with characteristics of MetS in apparently healthy overweight and obese adults. We studied 92 adults; 59 men and 33 women whose average body mass index (BMI) was 28.15±5.08 kg/m 2. Anthropometric parameters, insulin resistance indices, lipid profiles, and inflammatory markers including high sensitivity C-reactive protein (hsCRP), pentraxin 3 (PTX3), adiponectin, and chemerin were measured. Controlling for age, gender, and BMI, serum chemerin level was positively correlated with body fat and serum triglyceride, and negatively correlated with adiponectin and high density lipoprotein cholesterol (HDL- C), and was not correlated with altered hsCRP or PTX3 levels. Among the low, moderate and high chemerin groups, high chemerin individuals are more likely to have lower HDL-C. Conversely, individuals in the low adiponectin group are more likely to have lower HDL-C and show more MetS phenotypic traits than moderate and high adiponectin subjects. To determine the relationships of chemerin and adiponectin to MetS and its components, participants were stratified into four groups based on their chemerin and adiponectin levels (high chemerin/high adiponectin, high chemerin/low adiponectin, low chemerin/high adiponectin, or low chemerin/low adiponectin). Participants who were in the high chemerin/low adiponectin group more likely to have dyslipidemia and MetS (OR: 5.79, 95% CI:1.00-33.70) compared to the other three group. Our findings suggest that chemerin and adiponectin may reciprocally participate in the development of MetS.

UR - http://www.scopus.com/inward/record.url?scp=84859567741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859567741&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0034710

DO - 10.1371/journal.pone.0034710

M3 - Article

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e34710

ER -